Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA; Department of Medicine, Duke University School of Medicine, Durham, NC 22710, USA.
Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA; Department of Medicine, Duke University School of Medicine, Durham, NC 22710, USA.
Cell Host Microbe. 2018 Jun 13;23(6):759-765.e6. doi: 10.1016/j.chom.2018.04.018. Epub 2018 May 31.
HIV-1 broadly neutralizing antibodies (bnAbs) require high levels of activation-induced cytidine deaminase (AID)-catalyzed somatic mutations for optimal neutralization potency. Probable mutations occur at sites of frequent AID activity, while improbable mutations occur where AID activity is infrequent. One bottleneck for induction of bnAbs is the evolution of viral envelopes (Envs) that can select bnAb B cell receptors (BCR) with improbable mutations. Here we define the probability of bnAb mutations and demonstrate the functional significance of key improbable mutations in three bnAb B cell lineages. We show that bnAbs are enriched for improbable mutations, which implies that their elicitation will be critical for successful vaccine induction of potent bnAb B cell lineages. We discuss a mutation-guided vaccine strategy for identification of Envs that can select B cells with BCRs that have key improbable mutations required for bnAb development.
HIV-1 广谱中和抗体(bnAbs)需要高水平的激活诱导胞苷脱氨酶(AID)催化的体细胞突变,以发挥最佳中和效力。可能的突变发生在 AID 活性频繁的部位,而不太可能的突变发生在 AID 活性不频繁的部位。诱导 bnAbs 的一个瓶颈是病毒包膜(Env)的进化,它可以选择具有不太可能突变的 bnAb B 细胞受体(BCR)。在这里,我们定义了 bnAb 突变的概率,并在三个 bnAb B 细胞谱系中证明了关键不太可能突变的功能意义。我们表明,bnAbs 富含不太可能的突变,这意味着它们的诱导对于成功诱导有效的 bnAb B 细胞谱系将是至关重要的。我们讨论了一种基于突变的疫苗策略,用于鉴定可以选择具有 bnAb 发育所需关键不太可能突变的 BCR 的 B 细胞的 Envs。